HY-RI03503A-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 antagomir
|
|
|
|
HY-RI03503A-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 antagomir
|
|
|
|
HY-RI03503-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 inhibitor
|
|
|
|
HY-RI03503-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 inhibitor
|
|
|
|
HY-R03503-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 mimic
|
|
Cancer-programmed cell death
|
|
HY-R03503-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 mimic
|
|
Cancer-programmed cell death
|
|
HY-16677A-10mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-16677A-100mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-16677A-5mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-16677A-50mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-16677A-1mL
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|